ArticleBlood2022

Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.

Shunsuke Kimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.